MindBio Appoints National Drug Policy & Mining Industry Expert to Lead South American Mining Industry Commercialisation

Vancouver, British Columbia – TheNewswire - February 24, 2026 – MindBio Therapeutics Corp. (CSE: MBIO | Frankfurt: WF6 | OTCQB: MBQIF) (“MindBio” or the “Company”), a biotechnology innovator commercializing AI-powered voice analytics for real-time drug and alcohol impairment detection, today announced the appointment of Felipe Leyton — one of South America’s most influential drug and alcohol policy architects and a recognized mining industry safety authority — to lead commercialization across the South Ame ...